Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report
- PMID: 27027540
- PMCID: PMC4814249
- DOI: 10.1111/cas.12889
Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report
Abstract
The Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer published its first report in July 2013 on the epidemiological assessment of the associations of diabetes with cancer risk/prognosis, the common risk factors for diabetes and cancer, and cancer risk associated with diabetes treatment. The Joint Committee continued its work to assess the role of glycemic control in the development of cancer in patients with diabetes. This review shows that high-quality evidence examining the association between glycemic control and cancer risk is lacking.
Keywords: Cancer; HbA1c; diabetes; glucose control; observational studies; randomized controlled trials.
© 2016 The Japanese Cancer Association and the Japan Diabetes Society. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
References
-
- Goto A, Noto H, Noda M et al Report of the JDS/JCA Joint Committee on Diabetes and Cancer, Second Report (In Japanese). J Japan Diabetes Soc 2016; 59: 174‐77. doi:10.11213/tonyobyo.59.174. - DOI
-
- Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta‐analysis. Endocr Pract 2011; 17: 616–28. - PubMed
-
- Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta‐analyses of observational studies. BMJ 2015; 350: g7607. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical